Fulgent Genetics (FLGT) Competitors $18.53 +1.35 (+7.86%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$19.03 +0.50 (+2.72%) As of 04:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT vs. ADUS, PGNY, VCYT, PACS, LFST, ARDT, NHC, GRAL, TDOC, and VRDNShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Addus HomeCare (ADUS), Progyny (PGNY), Veracyte (VCYT), PACS Group (PACS), LifeStance Health Group (LFST), Ardent Health (ARDT), National HealthCare (NHC), GRAIL (GRAL), Teladoc Health (TDOC), and Viridian Therapeutics (VRDN). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. Its Competitors Addus HomeCare Progyny Veracyte PACS Group LifeStance Health Group Ardent Health National HealthCare GRAIL Teladoc Health Viridian Therapeutics Addus HomeCare (NASDAQ:ADUS) and Fulgent Genetics (NASDAQ:FLGT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment. Which has preferable earnings & valuation, ADUS or FLGT? Addus HomeCare has higher revenue and earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAddus HomeCare$1.15B1.67$73.60M$4.4323.69Fulgent Genetics$283.47M1.99-$42.71M-$1.66-11.16 Which has more risk and volatility, ADUS or FLGT? Addus HomeCare has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Fulgent Genetics has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Do analysts prefer ADUS or FLGT? Addus HomeCare presently has a consensus price target of $142.57, suggesting a potential upside of 35.83%. Fulgent Genetics has a consensus price target of $24.00, suggesting a potential upside of 29.52%. Given Addus HomeCare's stronger consensus rating and higher probable upside, equities analysts clearly believe Addus HomeCare is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Addus HomeCare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is ADUS or FLGT more profitable? Addus HomeCare has a net margin of 6.52% compared to Fulgent Genetics' net margin of -16.83%. Addus HomeCare's return on equity of 9.23% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Addus HomeCare6.52% 9.23% 6.96% Fulgent Genetics -16.83%-2.26%-2.10% Do insiders and institutionals believe in ADUS or FLGT? 95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 48.1% of Fulgent Genetics shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 33.1% of Fulgent Genetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer ADUS or FLGT? In the previous week, Fulgent Genetics had 8 more articles in the media than Addus HomeCare. MarketBeat recorded 16 mentions for Fulgent Genetics and 8 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.30 beat Fulgent Genetics' score of 0.88 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fulgent Genetics 7 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAddus HomeCare beats Fulgent Genetics on 13 of the 17 factors compared between the two stocks. Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$564.05M$2.06B$5.52B$9.35BDividend YieldN/AN/A4.74%4.14%P/E Ratio-11.1636.0429.0523.78Price / Sales1.999.96444.6497.50Price / CashN/A54.1424.4827.20Price / Book0.509.068.365.61Net Income-$42.71M-$63.67M$3.25B$265.26M7 Day Performance2.83%-7.60%-3.57%-4.34%1 Month Performance-7.63%0.42%5.10%4.11%1 Year Performance-26.06%20.96%25.36%17.92% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics4.2087 of 5 stars$18.53+7.9%$24.00+29.5%-26.1%$564.05M$283.47M-11.161,313News CoverageEarnings ReportGap UpHigh Trading VolumeADUSAddus HomeCare4.9372 of 5 stars$109.11-0.3%$142.57+30.7%-12.8%$2.01B$1.15B24.6349,703Positive NewsPGNYProgyny1.8655 of 5 stars$23.20+0.4%$24.82+7.0%-16.1%$1.98B$1.17B40.70310Positive NewsUpcoming EarningsVCYTVeracyte2.7663 of 5 stars$25.02-0.9%$40.90+63.5%+9.4%$1.98B$445.76M61.03790Positive NewsUpcoming EarningsHigh Trading VolumePACSPACS Group3.2528 of 5 stars$11.83+1.2%$34.29+189.8%-70.0%$1.78B$3.56B0.0032,433Positive NewsUpcoming EarningsLFSTLifeStance Health Group3.1795 of 5 stars$4.17+0.7%$8.42+101.8%-32.4%$1.61B$1.25B-41.7010,218Upcoming EarningsARDTArdent Health3.7227 of 5 stars$10.67-3.5%$20.30+90.3%-41.1%$1.58B$5.97B6.5524,900Upcoming EarningsNHCNational HealthCareN/A$95.82-0.6%N/A-24.6%$1.48B$1.37B12.0112,400News CoverageGRALGRAIL1.0995 of 5 stars$38.27-5.0%$31.50-17.7%+97.6%$1.45B$125.60M-0.631,360Gap DownTDOCTeladoc Health3.4294 of 5 stars$8.18-0.2%$9.67+18.2%-12.7%$1.44B$2.55B-1.385,500Earnings ReportAnalyst RevisionVRDNViridian Therapeutics1.1761 of 5 stars$17.26-0.1%$37.00+114.4%+14.8%$1.41B$300K-4.4850Short Interest ↑ Related Companies and Tools Related Companies ADUS Competitors PGNY Competitors VCYT Competitors PACS Competitors LFST Competitors ARDT Competitors NHC Competitors GRAL Competitors TDOC Competitors VRDN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGT) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FLGT Stock Alerts